Article info

Download PDFPDF
Expression pattern and prognostic significance of myosin light chain 9 (MYL9): a novel biomarker in glioblastoma

Authors

  1. Correspondence to Professor Vani Santosh, Neuropathology, National Institute Of Mental Health and Neurosciences (NIMHANS), Bangalore 560029, Karnataka, India; vani.santosh{at}gmail.com
View Full Text

Citation

Kruthika BS, Sugur H, Nandaki K, et al
Expression pattern and prognostic significance of myosin light chain 9 (MYL9): a novel biomarker in glioblastoma

Publication history

  • Received March 10, 2019
  • Revised June 5, 2019
  • Accepted June 7, 2019
  • First published July 3, 2019.
Online issue publication 
September 19, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.